Skip to main content
logo
REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
13.62
-0.14 (-1.02%)
At close: Jan 16, 2026, 4:00 PM EST
13.70
+0.08 (0.59%)
After-hours: Jan 16, 2026, 7:47 PM EST

REGENXBIO Employees

REGENXBIO had 353 employees as of December 31, 2024. The number of employees increased by 9 or 2.62% compared to the previous year.

Employees
353
Change (1Y)
9
Growth (1Y)
2.62%
Revenue / Employee
$456,992
Profits / Employee
-$504,008
Market Cap
689.49M

Employees Chart

Employees History

DateEmployeesChangeGrowth
Dec 31, 202435392.62%
Dec 31, 2023344-57-14.21%
Dec 31, 2022401297.80%
Dec 31, 20213726621.57%
Dec 31, 20203064919.07%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Related Stocks

Company NameEmployees
UnitedHealth Group400,000
Johnson & Johnson138,100
Thermo Fisher Scientific125,000
Abbott Laboratories114,000
AstraZeneca92,900
Novo Nordisk77,349
Novartis AG75,883
Merck & Co.75,000
Employee Rankings

RGNX News

More News